Patents by Inventor John E. Mills
John E. Mills has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11993404Abstract: Satellites having autonomously deployable solar arrays are disclosed. A disclosed example satellite includes a solar array, a sensor to detect that the satellite has exited a launch vehicle, a processor to, based on the satellite exiting the launch vehicle, enable release of magnets or locks of an array, a release controller to control the release of the magnets or the locks of the array based on a release sequence to autonomously deploy the solar array, and a sequence analyzer to adapt the release sequence during execution of the release sequence, wherein adapting the release sequence includes changing an order in which the magnets or the locks of the array are released based on a degree to which the solar array is unfolded.Type: GrantFiled: December 13, 2022Date of Patent: May 28, 2024Assignee: The Boeing CompanyInventors: Gary E. Lemke, Chris J. Wasson, John P. Mills, Cecilia G. Cantu
-
Patent number: 11920310Abstract: A bollard assembly is formed from a bollard that resides in a tubular socket. The socket has an internal core that is separated from the tube walls by annular recess. The lower end of the bollard is received within the recess. Lifting elements inside the bollard engage the upper surface of the core, and are internally biased in favor of extension. A locking system prevents extension of the lifting elements. When the locking system is unlocked, the pressure of the lifting elements against the core causes the bollard to rise out of and slightly above the socket, without external assistance. Once raised, the bollard may easily be removed from the site of the socket.Type: GrantFiled: April 26, 2022Date of Patent: March 5, 2024Assignee: Ameristar Perimeter Security USA Inc.Inventors: Douglas E. Mills, Christopher M. Tabler, John D. Bell, Bradley M. Chandler
-
Patent number: 9321729Abstract: Certain substituted pyridyl amide compounds are histamine H3 receptor modulators useful in the treatment of histamine H3 receptor-mediated diseases.Type: GrantFiled: December 4, 2014Date of Patent: April 26, 2016Assignee: Janssen Pharmaceutica NVInventors: John M. Keith, Michael A. Letavic, Kiev S. Ly, Neelakandha S. Mani, John E. Mills, Chennagiri R. Pandit, Frank J. Villani, Hua Zhong
-
Publication number: 20150087635Abstract: Certain substituted pyridyl amide compounds are histamine H3 receptor modulators useful in the treatment of histamine H3 receptor-mediated diseases.Type: ApplicationFiled: December 4, 2014Publication date: March 26, 2015Inventors: John M. Keith, Michael A. Letavic, Kiev S. Ly, Neelakandha S. Mani, John E. Mills, Chennagiri R. Pandit, Frank J. Villani, Hua Zhong
-
Patent number: 8940731Abstract: Certain substituted pyridyl amide compounds are histamine H3 receptor modulators useful in the treatment of histamine H3 receptor-mediated diseases.Type: GrantFiled: December 18, 2013Date of Patent: January 27, 2015Assignee: Janssen Pharmaceutica NVInventors: John M. Keith, Michael A. Letavic, Kiev S. Ly, Neelakandha S. Mani, John E. Mills, Chennagiri R. Pandit, Frank J. Villani, Hua Zhong
-
Publication number: 20140107105Abstract: Certain substituted pyridyl amide compounds are histamine H3 receptor modulators useful in the treatment of histamine H3 receptor-mediated diseases.Type: ApplicationFiled: December 18, 2013Publication date: April 17, 2014Applicant: Janssen Pharmaceutica NVInventors: John M. Keith, Michael A. Letavic, Kiev S. Ly, Neelakandha S. Mani, John E. Mills, Chennagiri R. Pandit, Frank J. Villani, Hua Zhong
-
Patent number: 8637520Abstract: Certain substituted pyridyl amide compounds are histamine H3 receptor modulators useful in the treatment of histamine H3 receptor-mediated diseases.Type: GrantFiled: July 1, 2010Date of Patent: January 28, 2014Assignee: Janssen Pharmaceutica NVInventors: John M. Keith, Michael A. Letavic, Kiev S. Ly, Neelakandha S. Mani, John E. Mills, Chennagiri R. Pandit, Frank J. Villani, Hua Zhong
-
Publication number: 20100267701Abstract: Certain substituted pyridyl amide compounds are histamine H3 receptor modulators useful in the treatment of histamine H3 receptor-mediated diseases.Type: ApplicationFiled: July 1, 2010Publication date: October 21, 2010Inventors: John M. Keith, Michael A. Letavic, Kiev S. Ly, Neelakandha S. Mani, John E. Mills, Chennagiri R. Pandit, Frank J. Villani, Hua Zhong
-
Patent number: 7777031Abstract: Processes are disclosed for making certain compounds of Formula (II): or their pharmaceutically active salts, that are histamine H3 receptor modulators useful in the treatment of histamine H3 receptor-mediated diseases. In one embodiment, the process comprises reacting a compound of formula (7-1): with a compound of formula (B3): in the presence of at least one equivalent of a first base, in a first organic solvent, to give a compound of Formula (II).Type: GrantFiled: May 25, 2007Date of Patent: August 17, 2010Assignee: Janssen Pharmaceutica NVInventors: Neelakandha S. Mani, John E. Mills, Chennagiri R. Pandit, Frank J. Villani, Hua Zhong
-
Publication number: 20070281923Abstract: Certain substituted pyridyl amide compounds are histamine H3 receptor modulators useful in the treatment of histamine H3 receptor-mediated diseases.Type: ApplicationFiled: May 25, 2007Publication date: December 6, 2007Inventors: John M. Keith, Michael A. Letavic, Kiev S. Ly, Neelakandha S. Mani, John E. Mills, Chennagiri R. Pandit, Frank J. Villani, Hua Zhong
-
Patent number: 6191194Abstract: Silicone rubber compositions are disclosed including a silicone polymer and a silicon-treated carbon black. The silicon-treated carbon blacks include a silicon-containing compound that is distributed through at least a portion of the carbon black aggregate. The silicon-treated carbon black is incorporated within a silicone rubber composition as an alternative reinforcing and extending filler, imparting higher hardness to elastomers formed from the composition, when compared to silicone rubber compositions incorporating an untreated carbon black.Type: GrantFiled: November 12, 1999Date of Patent: February 20, 2001Assignee: Cabot CorporationInventors: Joginder N. Anand, John E. Mills, Steven R. Reznek
-
Patent number: 6020402Abstract: Silicone rubber compositions are disclosed including a silicone polymer and a silicon-treated carbon black. The silicon-treated carbon blacks include a silicon-containing compound that is distributed through at least a portion of the carbon black aggregate. The silicon-treated carbon black is incorporated within a silicone rubber composition as an alternative reinforcing and extending filler, imparting higher hardness to elastomers formed from the composition, when compared to silicone rubber compositions incorporating an untreated carbon black.Type: GrantFiled: September 15, 1995Date of Patent: February 1, 2000Assignee: Cabot CorporationInventors: Joginder N. Anand, John E. Mills, Steven R. Reznek
-
Patent number: 4798893Abstract: A method for the synthesis of the 2-propanone (I) is described starting from alkoxide (II) through the lactone (IV). ##STR1## Excellent control of the location of the substitution on the phenyl ring is achieved and the reaction proceeds in high yield.Type: GrantFiled: September 21, 1987Date of Patent: January 17, 1989Assignee: McNeilab, Inc.Inventors: David A. Cherry, Cynthia A. Maryanoff, John E. Mills, Roy A. Olofson, James D. Rodgers
-
Patent number: 4704560Abstract: A digital pulsewidth modulator switch regulator is used in a power supply for a multisection vacuum fluorescent display system. Pulsewidth modulations are based on grid and anode load characteristics of each section of the display, stored prior to system operations in a designated location of memory of a microcomputer used for controlling switching regulations. Display voltage updates are made utilizing the stored data as well as new load data derived from the power supply output voltage feedback signals indicative of changes in the display voltage.Type: GrantFiled: October 6, 1986Date of Patent: November 3, 1987Assignee: Chrysler Motors CorporationInventors: John E. Mills, Michael A. Dahl
-
Patent number: 4528382Abstract: Novel compounds, which are aryl-pyrrolyl-imine derivatives of the Formula I ##STR1## and acid addition salts thereof are disclosed; which compounds may be prepared by the acid catalyzed condensation of an imidoyl chloride with a lower alkyl pyrrole-2-acetate; and which compounds are useful as intermediates to form by hydrolysis, the known useful ketone analogs which have anti-inflammatory and analgesic activity; and certain of which compounds have antisecretory, anti-irritable bowel, antidiarrheal and general behavior effect on the CNS properties.Type: GrantFiled: November 16, 1982Date of Patent: July 9, 1985Assignee: McNeilab, Inc.Inventor: John E. Mills
-
Patent number: 4499274Abstract: An improved process for preparing fenoctimine, which is 4-(diphenylmethyl)-1-[(octylimino)methyl]piperidine by: (1) reacting dimethylformamide with dimethyl sulfate to form a complex; (2) reacting the resultant dimethylformamide/dimethyl sulfate complex with n-octylamine and optionally with dimethylamine; (3) thereafter treating the reaction with aqueous base to form N,N-dimethyl-N'-octyl-formamidine; and (4) reacting said formamidine, without need for further purification, with 4-(diphenylmethyl) piperidine to obtain 4-(diphenylmethyl)-1-[(octylimino)-methyl]piperidine.Type: GrantFiled: March 17, 1983Date of Patent: February 12, 1985Assignee: McNeilab, Inc.Inventors: Georg Feth, John E. Mills
-
Patent number: 4147706Abstract: There is provided a novel method of synthesizing certain tetracyclic quinones. In particular, there is provided a novel route to the synthesis of (+)-7-deoxydaunomycinone and analogs thereof, which includes the provision of novel tri- and tetracyclic quinone intermediates. The -7-deoxydaunomycinone derived from naturally occurring daunomycin is a known compound, which is itself an intermediate in the preparation of the clinically accepted anti-tumor antibiotics daunomycine and its derivative adriamycin.Type: GrantFiled: January 10, 1978Date of Patent: April 3, 1979Assignee: Research CorporationInventors: Andrew S. Kende, John E. Mills, Yuh-Geng Tsay
-
Patent number: 4070382Abstract: There is provided a novel method of synthesizing certain tetracyclic quinones. In particular, there is provided a novel route to the synthesis of (.+-.)-7-deoxydaunomycinone and analogs thereof, which includes the provision of novel tri- and tetracyclic quinone intermediates. The -7-deoxydaunomycinone derived from naturally occurring daunomycin is a known compound, which is itself an intermediate in the preparation of the clinically accepted anti-tumor antibiotics daunomycine and its derivative adriamycin.Type: GrantFiled: November 18, 1975Date of Patent: January 24, 1978Assignee: Research CorporationInventors: Andrew S. Kende, John E. Mills, Yuh-Geng Tsay
-
Patent number: 4021457Abstract: There is provided a novel method of synthesizing certain tetracyclic quinones. In particular, there is provided a novel route to the synthesis of certain analogs of (+)-7-deoxydaunomycinone which includes the provision of novel tri- and tetracyclic quinone intermediates. The products of the synthetic route provided herein may be converted into compounds of known anti-neoplastic activity.Type: GrantFiled: April 5, 1976Date of Patent: May 3, 1977Assignee: Research CorporationInventors: Andrew S. Kende, John E. Mills, Yuh-Geng Tsay